NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD
  • XY Feed
  • 24-HOUR Pass ↗
  • Push Notifications
Sign in Subscribe

Perfect Corp. to Go Private in $2.00-Per-Share Deal Led by Chairwoman Alice Chang

Transaction expected to close in Q4 2026.

Perfect Corp. to Go Private in $2.00-Per-Share Deal Led by Chairwoman Alice Chang
"Software entrepreneur Alice Chang." Credit: Perfect Corp.
Already have an account? Sign in.
07/10/2026 · 8:21 AM
PERF
/ Don’t stop at just one post.

Related↓

Perfect Corp. Shares Soar on CEO-Led $1.95 Buyout Proposal
03/18/2026 · 10:53 AM

Perfect Corp. Shares Soar on CEO-Led $1.95 Buyout Proposal

Perfect Corp. shares jump 29% after receiving a non-binding $1.95-per-share buyout proposal from a group led by CEO Alice H. Chang, representing a 44% premium.

/ Subscriber only
/ Read more

Feed↓

Rigetti Shares Fall After Q3 Revenue Miss and Soft Full-Year Outlook
11/10/2026 · 4:30 PM

Rigetti Shares Fall After Q3 Revenue Miss and Soft Full-Year Outlook

Rigetti stock dropped after Q3 revenue of $1.4 million missed estimates and full-year guidance of about $20 million fell short of analyst expectations.

/ Subscriber only
CoreWeave Shares Rise After Strong Q3 Beat and Raised Guidance
Featured/ 11/10/2026 · 4:17 PM

CoreWeave Stock Climbs as Margins Expand Faster Than Expected

CoreWeave shares rose after a strong Q3 beat, with revenue up more than $1B sequentially and margins hitting double digits ahead of plan.

/ Subscriber only
PepGen Stock Soars on Best-in-Class Phase 2 Results for Myotonic Dystrophy Drug
Featured/ 11/10/2026 · 11:31 AM

PepGen Stock Soars on Best-in-Class Phase 2 Results for Myotonic Dystrophy Drug

Phase 2 FREEDOM2 results for PGN-EDODM1 deliver 46.5% mean splicing correction, functional improvements, and strong analyst support.

/ Subscriber only
Explore
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD
  • XY Feed
  • 24-HOUR Pass ↗
  • Push Notifications
More
  • Sign up
  • Sign in
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Terms/Privacy
  • UP↑
Get alerts

Be the first to know when deals break, stocks move, or biotech headlines hit.

Email address Subscribe
DON'T FALL BEHIND. ©2026
For informational purposes only. Not financial advice.
NOTRELOAD AI